Principal MIDD consultant
Pharmetheus
Dr. Celine Sarr (Dartois) obtained her PhD from Lyon University in 2006 and then joined Novartis where she stayed 8 years working from Switzerland, New-Jersey and also Germany. Her work focused on providing strategic thinking and application of modelling and simulation to enhance and guide drug development programs spanning from Phase I to life-cycle management, but also on supporting regulatory interactions and submissions. She led the modeling and simulation team for Oncology business unit. Then after one year at Exprimo, she joined Pharmetheus in 2016. Currently, she supports clients in planning their strategy and submission and also in assessing efficacy and safety readouts of their compounds. She leads a team of 8 modelers and has relevant experience in PK, continuous and non-continuous endpoints, MIDD applications and accelerated submissions.
Disclosure information not submitted.
Pharmacometrics implementation and efficient execution
Saturday, October 18, 2025
2:00 PM - 2:45 PM MDT